Bram Verstockt

Bram Verstockt, MD, PhD, is Assistant Professor at KU Leuven and IBD Staff Member at the Department of Gastroenterology and Hepatology at University Hospitals Leuven in Belgium. Besides the regular IBD care, he is also responsible for the multidisciplinary IBD clinic and the implementation of intestinal ultrasound (IUS) in the Leuven IBD Unit.

Bram Verstockt graduated medical school at KU Leuven in 2013, and interrupted his residency to start a PhD which he successfully defended in 2019. During the first year of his PhD, he worked at the University of Cambridge, UK. In 2021, he performed an additional fellowship in Lüneburg (Germany) for intestinal ultrasound.

Besides clinical trials as PI or co-investigator, his clinical research focusses on non-invasive monitoring – including IUS – and the optimisation of radiology tools (radiomics). His translational research mainly focusses on the development of predictive/prognostic markers for a more personalised medicine in IBD, as well as on further unravelling IBD disease heterogeneity (including perianal disease, fibrostricturing disease and fatigue) trough multi-omics and organoid models. Together with Jonas Halfvarson and Séverine Vermeire, he co-founded the international COLLIBRI proteomics consortium.

Bram Verstockt is currently Y-ECCO Chair and Chair of the Belgian IBD Biobank. He is board member of the International Bowel Ultrasound (IBUS) Scientific Committee and the Belgian IBD Scientific Committee. Finally, he is associate editor at the Journal of Crohn’s and Colitis, and reviewer for many gastroenterology journals and conferences.